Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has complicated the management of inflammatory bowel diseases (IBD). OBJECTIVES: This study aimed to assess the efficacy of different anti-SARS-CoV-2 vaccines under different treatments in IBD patients and identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Resál, Tamás, Bacsur, Péter, Horváth, Miklós, Szántó, Kata, Rutka, Mariann, Bálint, Anita, Fábián, Anna, Bor, Renáta, Szepes, Zoltán, Fekete, János, Farkas, Klaudia, Miheller, Pál, Molnár, Tamás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350576/
https://www.ncbi.nlm.nih.gov/pubmed/37461738
http://dx.doi.org/10.1177/17562848231183529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350576/
https://www.ncbi.nlm.nih.gov/pubmed/37461738
http://dx.doi.org/10.1177/17562848231183529

Ejemplares similares